BioCentury
ARTICLE | Clinical News

Juvaris preclinical data

October 11, 2010 7:00 AM UTC

In mouse models of AML, JVRS-100 significantly increased survival vs. untreated controls. Furthermore, mice whose initial leukemia was successfully treated by JVRS-100 survived significantly longer in...